Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2020-10-09

Clinical Trial Update: Manuka Eye Droops for Treatment of Allergy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial for Manuka Eye Droops for allergic conjunctivitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Manuka Eye Droops

Snippet

Sponsor: Toyos Clinic | Conditions: Allergic Conjunctivitis | Phase 4 | Status: WITHDRAWN